Comparative effectiveness of finerenone versus steroidal mineralocorticoid receptor antagonists on sepsis-induced cardiomyopathy in patients with diabetic kidney disease: a real-world cohort study.

Wu JY, Lee KW, Huang SC, Chang HY, Lin YM

Open source

DOI
10.3389/fphar.2026.1837944
Published
2026
Container
Frontiers in pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1837944,
  title = {Comparative effectiveness of finerenone versus steroidal mineralocorticoid receptor antagonists on sepsis-induced cardiomyopathy in patients with diabetic kidney disease: a real-world cohort study.},
  author = {Wu JY and Lee KW and Huang SC and Chang HY and Lin YM},
  year = {2026},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2026.1837944},
  url = {https://doi.org/10.3389/fphar.2026.1837944}
}

RIS

TY  - JOUR
TI  - Comparative effectiveness of finerenone versus steroidal mineralocorticoid receptor antagonists on sepsis-induced cardiomyopathy in patients with diabetic kidney disease: a real-world cohort study.
AU  - Wu JY
AU  - Lee KW
AU  - Huang SC
AU  - Chang HY
AU  - Lin YM
PY  - 2026
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2026.1837944
UR  - https://doi.org/10.3389/fphar.2026.1837944
ER  - 

APA

JY, W., KW, L., SC, H., HY, C., & YM, L. (2026). Comparative effectiveness of finerenone versus steroidal mineralocorticoid receptor antagonists on sepsis-induced cardiomyopathy in patients with diabetic kidney disease: a real-world cohort study.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2026.1837944

Source records